Search

Author/Creator Hach, Thomas

4. Cryptococcal Meningitis Reported With Fingolimod Treatment: Case Series. Issue 3 (22nd May 2022)

Authors:
Del Poeta, Maurizio; Ward, Brian J.; Greenberg, Benjamin; Hemmer, Bernhard; Cree, Bruce A.C.; Komatireddy, Sreelatha; Mishra, Jitendriya; Sullivan, Roseanne; Kilaru, Ajay; Moore, Alan; Hach, Thomas; Berger, Joseph R.
Journal:
Neurology
Issue:
Volume 9:Issue 3(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Effect of siponimod on magnetic resonance imaging measures of neurodegeneration and myelination in secondary progressive multiple sclerosis: Gray matter atrophy and magnetization transfer ratio analyses from the EXPAND phase 3 trial. (September 2022)

Authors:
Arnold, Douglas L; Piani-Meier, Daniela; Bar-Or, Amit; Benedict, Ralph HB; Cree, Bruce AC; Giovannoni, Gavin; Gold, Ralf; Vermersch, Patrick; Arnould, Sophie; Dahlke, Frank; Hach, Thomas; Ritter, Shannon; Karlsson, Göril; Kappos, Ludwig; Fox, Robert J
Journal:
Multiple sclerosis
Issue:
Volume 28:Number 10(2022)
Page Start:
1526
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Patient-reported outcome measures in MS: Do development processes and patient involvement support valid quantification of clinically important variables?. Issue 2 (April 2022)

Authors:
Bharadia, Trishna; Vandercappellen, Jo; Chitnis, Tanuja; Eelen, Piet; Bauer, Birgit; Brichetto, Giampaolo; Lloyd, Andrew; Schmidt, Hollie; King, Miriam; Fitzgerald, Jennifer; Hach, Thomas; Hobart, Jeremy
Journal:
Multiple sclerosis journal, experimental, translational and clinical
Issue:
Volume 8:Issue 2(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Proportion and characteristics of secondary progressive multiple sclerosis in five European registries using objective classifiers. Issue 1 (January 2023)

Authors:
Forsberg, Lars; Spelman, Tim; Klyve, Pernilla; Manouchehrinia, Ali; Ramanujam, Ryan; Mouresan, Elena; Drahota, Jiri; Horakova, Dana; Joensen, Hanna; Pontieri, Luigi; Magyari, Melinda; Ellenberger, David; Stahmann, Alexander; Rodgers, Jeff; Witts, James; Middleton, Rod; Nicholas, Richard; Bezlyak,...
Journal:
Multiple sclerosis journal, experimental, translational and clinical
Issue:
Volume 9:Issue 1(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Secondary Progressive Multiple Sclerosis: A Review of Clinical Characteristics, Definition, Prognostic Tools, and Disease-Modifying Therapies. Issue 1 (22nd January 2023)

Authors:
Ziemssen, Tjalf; Bhan, Virender; Chataway, Jeremy; Chitnis, Tanuja; Campbell Cree, Bruce Anthony; Havrdova, Eva Kubala; Kappos, Ludwig; Labauge, Pierre; Miller, Aaron; Nakahara, Jin; Oreja-Guevara, Celia; Palace, Jacqueline; Singer, Barry; Trojano, Maria; Patil, Ashwini; Rauser, Benedict; Hach, T...
Journal:
Neurology
Issue:
Volume 10:Issue 1(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Slope of change in HbA1c from baseline with empagliflozin compared with sitagliptin or glimepiride in patients with type 2 diabetes. Issue 2 (6th April 2018)

Authors:
DeFronzo, Ralph A.; Ferrannini, Ele; Schernthaner, Guntram; Hantel, Stefan; Elsasser, Ulrich; Lee, Christopher; Hach, Thomas; Lund, Søren S.
Journal:
Endocrinology, diabetes & metabolism
Issue:
Volume 1:Issue 2(2018)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗